A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

Clinical trial NCT03623529 · UNKNOWN

Trial details

NCT number: NCT03623529
Sponsor: La Jolla Pharmaceutical Company
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Catecholamine-resistant Hypotension (CRH)Distributive Shock High Output Shock Septic Shock

Start date: 2018-08-01
Primary completion: 2023-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.